After-Hours Stock Movers 03/18: (MRKR) (TKAT) (KNSA) Higher; (ROAD) (NKE) (HIMS) Lower (more...)

After-Hours Stock Movers

Marker Therapeutics (NASDAQ: MRKR) 26% HIGHER; Cantor Fitzgeraldinitiates coverage with an Overweight rating and a price target of $6.00.

Takung Art Co., Ltd. (NASDAQ: TKAT) 14.6% HIGHER; adds to gains on NFT craze

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) 11.9% HIGHER; announced the U.S. Food and Drug Administration (FDA) approved ARCALYST ® (rilonacept), a weekly, subcutaneously-injected, recombinant fusion protein that blocks interleukin-1 alpha (IL-1) and interleukin-1 beta (IL-1) signaling, for the treatment of recurrent pericarditis and reduction in risk of recurrence in adults and children 12 years and older. The commercial launch is expected in April 2021.

MP Materials (NYSE: MP) 9.9% HIGHER; reported Q4 EPS of $0.20, $0.15 better than the analyst estimate of $0.05. Revenue for the quarter came in at $42.2 million versus the consensus estimate of $47.23 million.

Construction Partners, Inc. (NASDAQ: ROAD) 4.1% LOWER; announced that certain affiliates of SunTx Capital Management Corp. intend to offer 2,000,000 shares of the Company's Class A common stock in an underwritten secondary offering. The selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 300,000 shares of Class A common stock.

FedEx (NYSE: FDX) 3.5% HIGHER; reported Q3 EPS of $3.47, $0.23 better than the analyst estimate of $3.24. Revenue for the quarter came in at $21.5 billion versus the consensus estimate of $19.96 billion. FedEx sees FY2021 EPS of $17.60-$18.20, may not compare to consensus of $17.40.

Nike (NYSE: NKE) 3.2% LOWER; reported Q3 EPS of $0.90, $0.15 better than the analyst estimate of $0.75. Revenue for the quarter came in at $10.4 billion versus the consensus estimate of $11.04 billion.

Hims & Hers Health, Inc. (NYSE: HIMS) 2.9% LOWER; reported Q4 EPS of ($0.07), versus ($0.16) reported last year. Revenue for the quarter came in at $41.47 million, versus $41.32 million reported last year.

Ollie's Bargain Outlet (NASDAQ: OLLI) 2.3% HIGHER; reported Q4 EPS of $0.97, $0.12 better than the analyst estimate of $0.85. Revenue for the quarter came in at $515.8 million versus the consensus estimate of $488.37 million.

You May Also Be Interested In

• After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
• Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
• Tarsus Pharmaceuticals (TARS) Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon